Literature DB >> 35652674

Distinct forms of migration and mobility are differentially associated with HIV treatment adherence.

Pamela M Murnane1,2, Monica Gandhi3,4, Peter Bacchetti1, Monica Getahun5, Sarah A Gutin6, Hideaki Okochi3,4, Irene Maeri7, Patrick Eyul8, Daniel Omoding8, Jaffer Okiring9, Regina Tallerico3,4, Alexander Louie3,4, Adam Akullian10, Moses R Kamya8,11, Elizabeth A Bukusi5,7, Edwin D Charlebois6, Carol S Camlin5,6.   

Abstract

OBJECTIVE: We examined whether human mobility was associated with antiretroviral treatment adherence, measured via antiretroviral hair concentrations.
DESIGN: This is a cross-sectional analysis of adults on antiretroviral treatment in East Africa at baseline in an observational cohort study.
METHODS: Participants reported recent mobility (overnight travel) and histories of migration (changes of residence), including reasons, frequency/duration, and locations. Hair antiretroviral concentrations were analyzed using validated methods. We estimated associations between mobility and antiretroviral concentrations via linear regression adjusted for age, sex, region, years on treatment.
RESULTS: Among 383 participants, half were women and the median age was 40. Among men, 25% reported recent work-related mobility, 30% nonwork mobility, and 11% migrated in the past year (mostly across district boundaries); among women, 6 and 57% reported work-related and nonwork mobility, respectively, and 8% recently migrated (mostly within district). Those reporting work-related trips 2 nights or less had 72% higher hair antiretroviral levels (P = 0.02) than those who did not travel for work; in contrast, nonwork mobility (any duration, vs. none) was associated with 24% lower levels (P = 0.06). Intra-district migrations were associated with 59% lower antiretroviral levels than nonmigrants (P = 0.003) while inter-district migrations were not (27% higher, P = 0.40).
CONCLUSION: We found that localized/intra-district migration and nonwork travel-more common among women-were associated with lower adherence, potentially reflecting care interruptions or staying with family/friends unaware of the participants' status. In contrast, short work-related trips-more common among men-were associated with higher adherence, perhaps reflecting higher income. Adherence interventions may require tailoring by sex and forms of mobility.
Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 35652674      PMCID: PMC9178682          DOI: 10.1097/QAD.0000000000003213

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.632


  42 in total

1.  Hair as a biological specimen for therapeutic drug monitoring.

Authors:  J H Beumer; I J Bosman; R A Maes
Journal:  Int J Clin Pract       Date:  2001 Jul-Aug       Impact factor: 2.503

2.  No adjustments are needed for multiple comparisons.

Authors:  K J Rothman
Journal:  Epidemiology       Date:  1990-01       Impact factor: 4.822

3.  Patterns of geographic mobility predict barriers to engagement in HIV care and antiretroviral treatment adherence.

Authors:  Barbara S Taylor; Emily Reyes; Elizabeth A Levine; Shah Z Khan; L Sergio Garduño; Yeycy Donastorg; Scott M Hammer; Karen Brudney; Jennifer S Hirsch
Journal:  AIDS Patient Care STDS       Date:  2014-05-19       Impact factor: 5.078

4.  Prevention of HIV-1 infection with early antiretroviral therapy.

Authors:  Myron S Cohen; Ying Q Chen; Marybeth McCauley; Theresa Gamble; Mina C Hosseinipour; Nagalingeswaran Kumarasamy; James G Hakim; Johnstone Kumwenda; Beatriz Grinsztejn; Jose H S Pilotto; Sheela V Godbole; Sanjay Mehendale; Suwat Chariyalertsak; Breno R Santos; Kenneth H Mayer; Irving F Hoffman; Susan H Eshleman; Estelle Piwowar-Manning; Lei Wang; Joseph Makhema; Lisa A Mills; Guy de Bruyn; Ian Sanne; Joseph Eron; Joel Gallant; Diane Havlir; Susan Swindells; Heather Ribaudo; Vanessa Elharrar; David Burns; Taha E Taha; Karin Nielsen-Saines; David Celentano; Max Essex; Thomas R Fleming
Journal:  N Engl J Med       Date:  2011-07-18       Impact factor: 91.245

Review 5.  Mobility and its Effects on HIV Acquisition and Treatment Engagement: Recent Theoretical and Empirical Advances.

Authors:  Carol S Camlin; Edwin D Charlebois
Journal:  Curr HIV/AIDS Rep       Date:  2019-08       Impact factor: 5.071

6.  Assessing the association between self-report items for HIV pill adherence and biological measures.

Authors:  Ashraf Kagee; Adriaan Nel
Journal:  AIDS Care       Date:  2012-06-07

7.  Influences on Adherence to Antiretroviral Therapy (ART) in Early-Stage HIV Disease: Qualitative Study from Uganda and South Africa.

Authors:  Norma C Ware; Monique A Wyatt; Emily E Pisarski; Bosco M Bwana; Catherine Orrell; Stephen Asiimwe; Gideon Amanyire; Nicholas Musinguzi; David R Bangsberg; Jessica E Haberer
Journal:  AIDS Behav       Date:  2020-03-05

8.  Population mobility associated with higher risk sexual behaviour in eastern African communities participating in a Universal Testing and Treatment trial.

Authors:  Carol S Camlin; Adam Akullian; Torsten B Neilands; Monica Getahun; Patrick Eyul; Irene Maeri; Sarah Ssali; Elvin Geng; Monica Gandhi; Craig R Cohen; Moses R Kamya; Thomas Odeny; Elizabeth A Bukusi; Edwin D Charlebois
Journal:  J Int AIDS Soc       Date:  2018-07       Impact factor: 5.396

9.  Effect of ART scale-up and female migration intensity on risk of HIV acquisition: results from a population-based cohort in KwaZulu-Natal, South Africa.

Authors:  Armstrong Dzomba; Andrew Tomita; Alain Vandormael; Kaymarlin Govender; Frank Tanser
Journal:  BMC Public Health       Date:  2019-02-14       Impact factor: 3.295

10.  The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models.

Authors:  Mary K Grabowski; Justin Lessler; Andrew D Redd; Joseph Kagaayi; Oliver Laeyendecker; Anthony Ndyanabo; Martha I Nelson; Derek A T Cummings; John Baptiste Bwanika; Amy C Mueller; Steven J Reynolds; Supriya Munshaw; Stuart C Ray; Tom Lutalo; Jordyn Manucci; Aaron A R Tobian; Larry W Chang; Chris Beyrer; Jacky M Jennings; Fred Nalugoda; David Serwadda; Maria J Wawer; Thomas C Quinn; Ronald H Gray
Journal:  PLoS Med       Date:  2014-03-04       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.